144 related articles for article (PubMed ID: 35917167)
1. Prognostic Implications of Skin Invasion in Locally Advanced Oral Cavity Squamous Cell Carcinoma.
Diebolt JH; Yu KM; Wood S; Ziegler A; France A; Villwock MR; Alvi SA; Kakarala K; Shnayder Y; Gan GN; Lominska CE; Neupane P; Bur AM
Otolaryngol Head Neck Surg; 2023 Jul; 169(1):69-75. PubMed ID: 35917167
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study.
Kang CJ; Wen YW; Lee SR; Ng SH; Lee LA; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Tsai CY; Lin CH; Tsao CK; Fang TJ; Huang SF; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
Oral Oncol; 2022 Mar; 126():105750. PubMed ID: 35123256
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Clinical Outcomes, Pathologic Characteristics, and Immune-Related Features of Postradiation vs Sporadic Oral Cavity Squamous Cell Carcinoma.
Chow JCH; Cheuk W; Cho WCS; Wong CF; Au DWY; Tam AHP; Wong RCW; Chan JCH; Law SCC; Ngan RKC; Wong KH; Cheung KM
JAMA Netw Open; 2023 Jul; 6(7):e2323890. PubMed ID: 37459093
[TBL] [Abstract][Full Text] [Related]
4. Assessing Prognostic Value of Quantitative Neck Dissection Quality Measures in Patients With Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma.
Farrokhian N; Holcomb AJ; Dimon E; Karadaghy O; Ward C; Whiteford E; Tolan C; Hanly EK; Buchakjian MR; Harding B; Dooley L; Shinn J; Wood CB; Rohde S; Khaja S; Parikh A; Bulbul MG; Penn J; Goodwin S; Bur AM
JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):947-955. PubMed ID: 36074415
[TBL] [Abstract][Full Text] [Related]
5. Subcategorization of Perineural Invasion Stratifies Oral Cavity Squamous Cell Carcinoma Prognosis.
Fung N; Fleseriu CM; Harley RJ; Khan NI; Kim S
Laryngoscope; 2024 Apr; 134(4):1656-1662. PubMed ID: 37772957
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patients.
Holcomb AJ; Farrokhian N; Tolan C; Whiteford E; Villwock M; Kakarala K; Shnayder Y; Sykes K; Lominska C; Gan G; Buchakjian MR; Harding B; Dooley L; Shinn J; Burton Wood C; Rohde S; Khaja S; Abt NB; Varvares M; Bur AM
Oral Oncol; 2023 Jul; 142():106420. PubMed ID: 37182430
[TBL] [Abstract][Full Text] [Related]
7. Extent of Extranodal Extension in Oral Cavity Squamous Cell Carcinoma is Not Independently Associated With Overall or Disease-Free Survival at a 2.0-mm Threshold.
Best DL; Jazayeri HE; McHugh JB; Udager AM; Troost JP; Powell C; Moe J
J Oral Maxillofac Surg; 2022 Dec; 80(12):1978-1988. PubMed ID: 36179764
[TBL] [Abstract][Full Text] [Related]
8. Poor tumor differentiation is an independent adverse prognostic variable in patients with locally advanced oral cavity cancer--Comparison with pathological risk factors according to the NCCN guidelines.
Lee LY; Lin CY; Cheng NM; Tsai CY; Hsueh C; Fan KH; Wang HM; Hsieh CH; Ng SH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Kang CJ; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Liao CT
Cancer Med; 2021 Oct; 10(19):6627-6641. PubMed ID: 34533269
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy improves survival in pT4aN0 oral cavity squamous cell carcinoma with bone invasion.
Stanford-Moore GB; Sola AM; Chan J; El-Sayed I; George J; Ha P; Ryan WR; Heaton CM
Am J Otolaryngol; 2022; 43(2):103303. PubMed ID: 34894450
[TBL] [Abstract][Full Text] [Related]
10. Margin Assessment Methods in Oral Cavity Squamous Cell Carcinoma and Recurrence: Tumor Bed vs Resection Specimen Sampling.
Wu SS; Woody N; Hesse J; Cook S; Cracolici V; Ku JA; Prendes B; Silver N; Scharpf J; Brauer PR; Reddy CA; Campbell SR; Koyfman SA; Burkey B; Lamarre ED
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):1011-1020. PubMed ID: 37768650
[TBL] [Abstract][Full Text] [Related]
11. TNM 8 staging is a better prognosticator than TNM 7 for patients with locally advanced oral cavity squamous cell carcinoma treated with surgery and post-operative radiotherapy.
Sambasivan K; Sassoon I; Thavaraj S; Kennedy R; Doss G; Michaelidou A; Odell E; Sandison A; Hall G; Morgan P; Collins LHC; Lyons A; Cascarini L; Fry A; Oakley R; Simo R; Jeannon JP; Petkar I; Reis Ferreira M; Kong A; Lei M; Guerrero Urbano T
Radiother Oncol; 2021 Jul; 160():54-60. PubMed ID: 33845044
[TBL] [Abstract][Full Text] [Related]
12. Outcomes for recurrent oral cavity squamous cell carcinoma.
Contrera KJ; Zafereo ME; Yaniv D; Roberts DB; Gillenwater AM; Hanna EY; Weber RS; Myers JN; Chang EI; Garvey PB; Hanasono MM; Yu P; Hutcheson KA; Fuller CD; Tyler MA; Neskey DM
Oral Oncol; 2022 Nov; 134():106127. PubMed ID: 36155359
[TBL] [Abstract][Full Text] [Related]
13. Early relapse is an adverse prognostic factor for survival outcomes in patients with oral cavity squamous cell carcinoma: results from a nationwide registry study.
Tsai CY; Wen YW; Lee SR; Ng SH; Kang CJ; Lee LY; Hsueh C; Lin CY; Fan KH; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Cheng NM; Liao CT
BMC Cancer; 2023 Feb; 23(1):126. PubMed ID: 36750965
[TBL] [Abstract][Full Text] [Related]
14. Should sub-millimeter margins be deemed positive in oral cavity squamous cell carcinoma?
Kang CJ; Lee LY; Ng SH; Lin CY; Fan KH; Chen WC; Lin JC; Tsai YT; Lee SR; Chien CY; Hua CH; Ping Wang C; Chen TM; Terng SD; Tsai CY; Wang HM; Hsieh CH; Yeh CH; Lin CH; Tsao CK; Cheng NM; Fang TJ; Huang SF; Lee LA; Fang KH; Wang YC; Lin WN; Hsin LJ; Yen TC; Wen YW; Liao CT
Oral Oncol; 2024 Apr; 151():106745. PubMed ID: 38460286
[TBL] [Abstract][Full Text] [Related]
15. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of tumor mutational burden in patients with oral cavity squamous cell carcinoma treated with upfront surgery.
Moreira A; Poulet A; Masliah-Planchon J; Lecerf C; Vacher S; Larbi Chérif L; Dupain C; Marret G; Girard E; Syx L; Hoffmann C; Jeannot E; Klijanienko J; Guillou I; Mariani O; Dubray-Vautrin A; Badois N; Lesnik M; Choussy O; Calugaru V; Borcoman E; Baulande S; Legoix P; Albaud B; Servant N; Bieche I; Le Tourneau C; Kamal M
ESMO Open; 2021 Aug; 6(4):100178. PubMed ID: 34118772
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of extratumoral perineural invasion in patients with oral cavity squamous cell carcinoma.
Lee LY; De Paz D; Lin CY; Fan KH; Wang HM; Hsieh CH; Lee LA; Yen TC; Liao CT; Yeh CH; Kang CJ
Cancer Med; 2019 Oct; 8(14):6185-6194. PubMed ID: 31290283
[TBL] [Abstract][Full Text] [Related]
18. Redefining Perineural Invasion in Head and Neck Cutaneous Squamous Cell Carcinoma.
Cohen ER; Misztal C; Dable C; Gomez-Fernandez C; Bhatia RG; Roth P; Ma R; Trosman S; Green C; Nicolli E; Dinh CT; Sargi ZB
Otolaryngol Head Neck Surg; 2022 Oct; 167(4):705-715. PubMed ID: 35133896
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and immunohistochemical evaluation of oral and oropharyngeal squamous cell carcinoma in Chilean population.
Rivera C; González-Arriagada WA; Loyola-Brambilla M; de Almeida OP; Coletta RD; Venegas B
Int J Clin Exp Pathol; 2014; 7(9):5968-77. PubMed ID: 25337241
[TBL] [Abstract][Full Text] [Related]
20. Association of Neoadjuvant Pembrolizumab for Oral Cavity Squamous Cell Carcinoma With Adverse Events After Surgery in Treatment-Naive Patients.
Tang AL; O'Neil T; McDermott S; Tripathi S; Tikhtman R; Mark JR; Patil Y; Tabangin M; Altaye M; Wise-Draper TM; Zender CA
JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):935-939. PubMed ID: 36006622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
